GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA

巴雷特食管和食管腺癌的遗传决定因素

• 批准号: 9325717
• 负责人: AMITABH CHAK
• 金额: $ 46.3万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-26 至 2017-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9325717
• 关键词: Aberrant DNA Methylation; Ablation; Accounting; Adult; Affect; Barrett Esophagus; Basic Science; Biological; Biological Markers; Center for Translational Science Activities; Cessation of life; Characteristics; Chemoprevention; Chronic; Clinical; Clinical Investigator; Collaborations; DNA; Data; Detection; Development; Diagnosis; Disease; Distant; Early Detection Research Network; Endoscopy; Epidemiologist; Epigenetic Process; Epithelium; Esophageal Adenocarcinoma; Family member; Fostering; Foundations; Gastroesophageal reflux disease; Genetic; Genetic Determinism; Genetic Predisposition to Disease; Genetic screening method; Genomic DNA; Genomics; Goals; Human; In Situ; Incidence; Institution; Instruction; Knowledge; Laboratories; Laboratory Scientists; Lead; Malignant Neoplasms; Methods; MicroRNAs; Modeling; Molecular; Molecular Genetics; Morbidity - disease rate; Mucous Membrane; Obesity; Outcome; Patients; Physiological; Physiology; Pilot Projects; Productivity; Public Health; Publications; Recording of previous events; Research; Research Personnel; Research Project Grants; Risk; Schedule; Serological; Serum; Susceptibility Gene; Symptoms; Techniques; Testing; Therapeutic; Tissues; Translating; Translational Research; base; cancer diagnosis; cohort; deep sequencing; exome sequencing; family genetics; genetic pedigree; improved; improved outcome; male; meetings; molecular marker; mortality; outcome forecast; predicting response; prevent; programs; screening; symposium; transcriptome

DESCRIPTION (provided by applicant): The overall objectives of this BETRNet Translational Research Center (TRC-F) are: 1) to conduct a rigorous, integrated spectrum of transdisciplinary human research in Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) 2) to increase the biological understanding of key observations made by our clinical researchers (familial aggregation of BE and EAC, restitution of squamous mucosa after ablation); 3) to translate knowledge derived from genetic and physiologic research to solving clinical dilemmas in detection, prognosis, and therapy of BE in order to prevent EAC and improve the outcomes of EAC;4) to foster a transdisciplinary and translational research culture and to effectively expand and enhance scientific research focused on BE and EAC; 5) to evaluate research and transdisciplinary programs and to continuously Improve research, productivity and enhance translational implementation. These objectives build and synergize on existing multi-institutional collaborative networks and the considerable clinical, basic science, and translational expertise available at our institutions, focusing on improving the outcomes of patients with BE and EAC. The overarching organization framework for this TRCF proposal is 1) to focus research on understanding the genetic susceptibility, genomic and epigenetic changes that influence the development of BE and EAC; 2) to explore the physiologic, transcriptional, and epigenetic factors that lead to durable ablation of BE; and 3) to translate discoveries into applications that improve familial screening, effective detection, molecular prognostication, and durable ablation of BE.

描述（由申请人提供）：这个BETRNet转化研究中心（TRC-F）的总体目标是：1)对巴雷特食管（BE）和食管腺癌（EAC）进行严格的、综合的跨学科人体研究；2)增加对我们临床研究人员所做的关键观察（BE和EAC的家族聚集，消融后鳞状黏膜的恢复）的生物学理解；3)将遗传学和生理学的研究成果转化为解决BE的检测、预后和治疗等临床难题，以预防EAC并改善EAC的预后；4)培育跨学科和转化研究文化，有效扩展和加强以BE和EAC为重点的科学研究；5)评估研究和跨学科项目，并不断提高研究、生产力和提高转化实施。这些目标建立和协同现有的多机构合作网络和相当多的临床，基础科学和转化专业知识，在我们的机构提供，重点是改善患者的结果BE和EAC。该TRCF提案的总体组织框架是：1)重点研究影响BE和EAC发展的遗传易感性、基因组和表观遗传变化；2)探讨导致BE持续消融的生理、转录和表观遗传因素；3)将发现转化为应用，以改善家族性筛查、有效检测、分子预测和持久消融BE。